A Speedinvest portfolio company

Flinn

Sector
Health & Bio
Year Invested
2022
Enabling MedTech companies to automate quality & regulatory processes to launch and operate products 10x more efficiently.

Flinn's vision is to make high-quality health products accessible for everyone. The first major milestone on this journey is to enable medical device manufacturers to automate quality and regulatory processes. The go-to-market product sets the focus on the automation of post-market surveillance processes. This means automating the collection, evaluation, and reporting of relevant data through smart workflows, integrations, and the support of AI.

Austria
Share
Links
LinkedIn
Related Companies
aerska

Pioneering RNA medicines to treat, delay, and prevent diseases of the brain.

Sector
Health & Bio
Year Invested
2025
BlubBlub

Video modeling and gamified activities to help children improve their speech and language skills.

Sector
Marketplaces & Consumer
Health & Bio
Year Invested
2017
Charles.co

A digital clinic specializing in men’s health.

Sector
Health & Bio
Year Invested
2022
Doccla

Building the next-gen virtual ward company.

Sector
Health & Bio
Growth
Year Invested
2021
Fertifa

Enabling companies, large and small, to put DEI and employee well-being into practice.

Sector
Health & Bio
Year Invested
2022
Five Lives

Building digital tools for the tracking and improvement of cognitive health.

Sector
Health & Bio
Year Invested
2022
Flinn

Enabling MedTech companies to automate quality & regulatory processes to launch and operate products 10x more efficiently.

Sector
Health & Bio
Year Invested
2022
Fuse

Bringing price transparency to US healthcare.

Sector
Health & Bio
Year Invested
2025